| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 2524.78 | 2399.36 | 1671.24 | 1974.60 | 1691.61 |
| | | | | | |
| Net CashFlow From Operating Activities | 2413.38 | 2152.45 | 1813.30 | 919.78 | 1137.24 |
| Net Cash Used In Investing Activities | -12682.95 | -2081.69 | -1054.13 | -1369.14 | -1222.21 |
| Net Cash Used From Financing Activities | 10232.56 | 5.27 | -739.73 | 604.62 | -7.81 |
| Foreign Exchange Gains / Losses | 1.31 | 1.17 | 2.32 | 0.48 | 0.38 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 57.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 21.87 | 77.19 | 21.76 | 155.73 | -92.40 |
| Cash And Cash Equivalents Begin of Year | 382.01 | 304.82 | 283.06 | 127.33 | 219.73 |
| Cash And Cash Equivalents End Of Year | 403.88 | 382.01 | 304.82 | 283.06 | 127.33 |